URSO

This brand name is authorized in United States. It is also authorized in Canada, Japan.

Active ingredients

The drug URSO contains one active pharmaceutical ingredient (API):

1	Ursodeoxycholic acid UNII 724L30Y2QR - URSODIOL
	The ursodeoxycholic acid converts lithogenic bile in non-lithogenic bile and gradually dissolves the cholesterol gallstones.
	Read more about Ursodeoxycholic acid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
URSO 250 / FORTE Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A05AA02	Ursodeoxycholic acid	A Alimentary tract and metabolism → A05 Bile and liver therapy → A05A Bile therapy → A05AA Bile acid preparations
Discover more medicines within A05AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02238984, 02245894
JP	医薬品医療機器総合機構	2362001F1088, 2362001F2149
US	FDA, National Drug Code	58914-785, 58914-790